HealthInvest Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
50,872
+5,031
| +11% | +$439K | 1.9% | 21 |
|
|
2025
Q1 | $3.13M | Sell |
45,841
-14,216
| -24% | -$971K | 1.38% | 22 |
|
|
2024
Q4 | $4.68M | Buy |
60,057
+6,300
| +12% | +$491K | 2.22% | 16 |
|
|
2024
Q3 | $3.6M | Buy |
53,757
+19,274
| +56% | +$1.29M | 1.69% | 18 |
|
|
2024
Q2 | $3.91M | Buy |
34,483
+8,200
| +31% | +$930K | 2.38% | 12 |
|
|
2024
Q1 | $3.65M | Buy |
26,283
+8,226
| +46% | +$1.14M | 2.22% | 18 |
|
|
2023
Q4 | $2.24M | Buy |
+18,057
| New | +$2.24M | 1.75% | 21 |
|
|
2022
Q4 | $33.9K | Buy |
+299
| New | +$33.9K | 0.07% | 24 |
|